Estimated Percentage of Patients With Stable Coronary Heart Disease Candidates for PCSK9 Inhibitors

Rev Esp Cardiol (Engl Ed). 2019 Jun;72(6):518-519. doi: 10.1016/j.rec.2018.11.018. Epub 2019 Apr 10.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticholesteremic Agents / therapeutic use
  • Apoptosis
  • Cholesterol, LDL / blood
  • Coronary Disease / blood
  • Coronary Disease / drug therapy
  • Coronary Disease / epidemiology*
  • Ezetimibe / therapeutic use*
  • Humans
  • Incidence
  • PCSK9 Inhibitors*
  • Spain / epidemiology

Substances

  • Anticholesteremic Agents
  • Cholesterol, LDL
  • PCSK9 Inhibitors
  • PCSK9 protein, human
  • Ezetimibe